Ares Financial Consulting’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$132K Buy
1,030
+53
+5% +$6.2K 0.1% 115
2026
Q1
$118K Buy
977
+364
+59% +$42K 0.09% 112
2025
Q4
$64.5K Buy
+613
New +$57.5K 0.06% 137

Other funds holding MRK

Ares Financial Consulting's MRK Position: Q2 2026 in Review

Ares Financial Consulting increased its Merck (MRK) stake by 5.4% in Q2 2026, buying an estimated $6.2K and bringing the position to 1,030 shares worth $132K. The position accounts for 0.1% of the portfolio, ranked #115.

Ares Financial Consulting first reported a position in MRK in Q4 2025 and has held it in 3 quarters since. 2,223 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Ares Financial Consulting held 1,030 shares of Merck worth $132K as of Q2 2026.
  • Ares Financial Consulting bought 53 Merck shares in Q2 2026, an estimated $6.2K.
  • Merck made up 0.1% of Ares Financial Consulting's portfolio in Q2 2026, its #115 holding.
  • Ares Financial Consulting first reported a position in Merck in Q4 2025 and has held it in 3 quarters since.
  • 2,223 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Ares Financial Consulting's 13F filing for Q2 2026, filed 9 Jul 2026.